{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:25:01Z","timestamp":1787923501067,"version":"build-2784847793"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The fucosyltransferase 2 gene (FUT2) is responsible for the regulation of mucosal blood type antigens which can act as receptors for bacterial adhesion and regulate intestinal flora. A homozygous nonsense mutation in this gene leads to the absence of these antigens, termed FUT2 non-secretor status, and is associated with the development of Crohn\u2019s disease (CD). The mechanism of this association is likely via changes in homeostatic symbiosis, thus promoting development of inflammation. However, the impact of FUT2 genotype on CD phenotype and outcomes is not known.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Subjects were prospectively enrolled into a single-center translational IBD registry. All patients with CD who had available DNA extracted from peripheral blood for genotyping were included. Genotyping was performed using the rs601338-AA SNP, which represents the nonsense mutation (428GA) shown to be causing non-secretor status. Baseline demographics, disease phenotype, CD-related surgeries, and hospitalizations were also assessed retrospectively and statistically compared based on FUT2 genotype.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>635 patients with CD were included in the analysis, including 178 FUT2 wild-type (WT), 314 heterozygous (HET) and 143 homozygous (O) patients. The mean duration of follow-up was 8\u2009years and 2\u2009months. There were no statistically significant differences detected between genotypes when comparing sex, race, smoking status, body-mass index, and age of onset. Presence of extra-intestinal manifestations including arthritis, uveitis, erythema nodosum, pyoderma gangrenosum and primary sclerosing cholangitis, as well as disease location and behavior were also found to be similar when compared between O and WT, O and HET, and O and HET plus WT populations. The mean number of biologics used between groups was 1.50 (O), 1.39 (HET)and 1.42 (WT) (P\u2009=\u2009.55), with no difference in total duration of biologic therapy between groups. 60.8% of O patients used immunomodulators compared to 54.8% of HET and 59.6% of WT patients. In addition, there were no differences between groups in the number of patients who required more than one CD-related hospitalization (O\u2009=\u200930.1%, HET = 34.1%, WT = 30.3%) or surgery (O\u2009=\u200932.2%, HET = 39.5%, WT = 32%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this single-center analysis of 635 patients with CD, the FUT2 genotype was not associated with disease phenotype, disease severity, or clinical outcomes. These data suggest that while lack of fucosylation is associated with developing CD, it does not play a major role in driving disease progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/crocol\/otag094","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:49:36Z","timestamp":1786016976000},"source":"Crossref","is-referenced-by-count":0,"title":["FUT2 non-secretor status is not associated with disease phenotype or outcomes in patients with Crohn\u2019s disease"],"prefix":"10.1093","volume":"8","author":[{"given":"Rachel","family":"Lombard","sequence":"first","affiliation":[{"name":"University of Chicago Medicine, Department of Medicine , Chicago, IL,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfei","family":"Wang","sequence":"additional","affiliation":[{"name":"University of Chicago Medicine, Section of Gastroenterology Hepatology, and Nutrition , Chicago, IL,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Chervonsky","sequence":"additional","affiliation":[{"name":"University of Chicago, Committee on Immunology , Chicago, IL,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushila","family":"Dalal","sequence":"additional","affiliation":[{"name":"University of Chicago Medicine, Section of Gastroenterology Hepatology, and Nutrition , Chicago, IL,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell D","family":"Cohen","sequence":"additional","affiliation":[{"name":"University of Chicago Medicine, Section of Gastroenterology Hepatology, and Nutrition , Chicago, IL,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sakuraba","sequence":"additional","affiliation":[{"name":"Rush University, Section of Gastroenterology , Chicago, IL,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T","family":"Rubin","sequence":"additional","affiliation":[{"name":"University of Chicago Medicine, Section of Gastroenterology Hepatology, and Nutrition , Chicago, IL,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R","family":"Weber","sequence":"additional","affiliation":[{"name":"University of Chicago Medicine, Department of Pathology , Chicago, IL,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4790-8994","authenticated-orcid":false,"given":"Joel","family":"Pekow","sequence":"additional","affiliation":[{"name":"University of Chicago Medicine, Section of Gastroenterology Hepatology, and Nutrition , Chicago, IL,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"2026082719111539800_otag094-B1","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41588-023-01384-","article-title":"Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries","volume":"55","author":"Liu","year":"2023","journal-title":"Nat Genet"},{"key":"2026082719111539800_otag094-B2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/ng.3760","article-title":"Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease","volume":"49","author":"de Lange","year":"2017","journal-title":"Nat Genet"},{"key":"2026082719111539800_otag094-B3","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1093\/hmg\/ddq248","article-title":"Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn\u2019s disease","volume":"19","author":"McGovern","year":"2010","journal-title":"Hum Mol Genet"},{"key":"2026082719111539800_otag094-B4","doi-asserted-by":"publisher","first-page":"940196","DOI":"10.3389\/fmicb.2022.940196","article-title":"Fucosyltransferase 2: a genetic risk factor for intestinal diseases","volume":"13","author":"Hu","year":"2022","journal-title":"Front Microbiol"},{"key":"2026082719111539800_otag094-B5","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1074\/jbc.270.9.4640","article-title":"Sequence and expression of a candidate for the human secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype","volume":"270","author":"Kelly","year":"1995","journal-title":"J Biol Chem"},{"key":"2026082719111539800_otag094-B6","doi-asserted-by":"publisher","first-page":"4148651","DOI":"10.1155\/2017\/4148651","article-title":"Association of fucosyltransferase 2 gene polymorphisms with inflammatory bowel disease in patients from Southeast China","volume":"2017","author":"Wu","year":"2017","journal-title":"Gastroenterol Res Pract"},{"key":"2026082719111539800_otag094-B7","doi-asserted-by":"publisher","first-page":"19030","DOI":"10.1073\/pnas.1106408108","article-title":"Colonic mucosa-associated microbiota is influenced by an interaction of Crohn\u2019s disease and FUT2 (secretor) genotype","volume":"108","author":"Rausch","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026082719111539800_otag094-B8","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1097\/MCG.0000000000001626","article-title":"Fucosyltransferase 2 mutations are associated with a favorable clinical course in Crohn\u2019s disease","volume":"56","author":"Battat","year":"2022","journal-title":"J Clin Gastroenterol"},{"key":"2026082719111539800_otag094-B9","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nature13823","article-title":"Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness","volume":"514","author":"Pickard","year":"2014","journal-title":"Nature"},{"key":"2026082719111539800_otag094-B10","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.4049\/jimmunol.1500395","article-title":"Intestinal fucose as a mediator of host-microbe symbiosis","volume":"194","author":"Pickard","year":"2015","journal-title":"J Immunol"},{"key":"2026082719111539800_otag094-B11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41564-024-01873-w","article-title":"Bacterial and host fucosylation maintain IgA homeostasis to limit intestinal inflammation in mice","volume":"10","author":"Lei","year":"2025","journal-title":"Nat Microbiol"},{"key":"2026082719111539800_otag094-B12","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1093\/molbev\/msp108","article-title":"A natural history of FUT2 polymorphism in humans","volume":"26","author":"Ferrer-Admetlla","year":"2009","journal-title":"Mol Biol Evol."},{"key":"2026082719111539800_otag094-B13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cca.2021.02.019","article-title":"Estimation of secretor status of ABO antigens by high-resolution melting analysis of rs601338 (428G\u2009&gt;\u2009a)","volume":"517","author":"Soejima","year":"2021","journal-title":"Clin Chim Acta"},{"key":"2026082719111539800_otag094-B14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.12688\/wellcomeopenres.14636.2","article-title":"FUT2 secretor genotype and susceptibility to infections and chronic conditions in the ALSPAC cohort","volume":"3","author":"Azad","year":"2018","journal-title":"Wellcome Open Res"}],"container-title":["Crohn\u2019s &amp; Colitis 360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article-pdf\/8\/3\/otag094\/70507043\/otag094.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article-pdf\/8\/3\/otag094\/70507043\/otag094.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:43:10Z","timestamp":1787920990000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article\/doi\/10.1093\/crocol\/otag094\/8753150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7,8]]}},"URL":"https:\/\/doi.org\/10.1093\/crocol\/otag094","relation":{},"ISSN":["2631-827X"],"issn-type":[{"value":"2631-827X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,7]]},"article-number":"otag094"}}